Stocks and Investing Stocks and Investing
Thu, April 25, 2024

Joseph Stringer Maintained (CDTX) at Strong Buy with Increased Target to $25 on, Apr 25th, 2024


Published on 2024-10-28 10:37:48 - WOPRAI, Joseph Stringer
  Print publication without navigation


Joseph Stringer of Needham, Maintained "Cidara Therapeutics, Inc." (CDTX) at Strong Buy with Increased Target from $3 to $25 on, Apr 25th, 2024.

Joseph has made no other calls on CDTX in the last 4 months.



There is 1 other peer that has a rating on CDTX. Out of the 1 peers that are also analyzing CDTX, 0 agree with Joseph's Rating of Hold.



This is the rating of the analyst that currently disagrees with Joseph


  • Ed Arce of "HC Wainwright & Co." Maintained at Strong Buy and Held Target at $120 on, Monday, April 8th, 2024
Contributing Sources